Nicholas Timmins

3.3k total citations · 1 hit paper
53 papers, 2.5k citations indexed

About

Nicholas Timmins is a scholar working on General Health Professions, Molecular Biology and Oncology. According to data from OpenAlex, Nicholas Timmins has authored 53 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in General Health Professions, 13 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Nicholas Timmins's work include Health Services Management and Policy (8 papers), Healthcare Systems and Challenges (8 papers) and 3D Printing in Biomedical Research (7 papers). Nicholas Timmins is often cited by papers focused on Health Services Management and Policy (8 papers), Healthcare Systems and Challenges (8 papers) and 3D Printing in Biomedical Research (7 papers). Nicholas Timmins collaborates with scholars based in Australia, United States and United Kingdom. Nicholas Timmins's co-authors include Lars K. Nielsen, Stefanie Dietmair, Martin Fussenegger, Jens M. Kelm, Peter W. Zandstra, Peter P. Gray, Yonatan Y. Lipsitz, Jens O. Krömer, Mark P. Hodson and Lake‐Ee Quek and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

Nicholas Timmins

49 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types

2003 734 citations Nicholas Timmins, Lars K. Nielsen et al. Biotechnology and Bioengineering profile →

Peers

Countries citing papers authored by Nicholas Timmins

Since Specialization

Citations

This map shows the geographic impact of Nicholas Timmins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Timmins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Timmins more than expected).

Fields of papers citing papers by Nicholas Timmins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Timmins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Timmins. The network helps show where Nicholas Timmins may publish in the future.

Co-authorship network of co-authors of Nicholas Timmins

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Timmins. A scholar is included among the top collaborators of Nicholas Timmins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Timmins. Nicholas Timmins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The most expensive breakfast in history: revisiting the Wanless review 20 years on 2021 ·Nicholas Timmins	0
2	Achieving Efficient Manufacturing and Quality Assurance through Synthetic Cell Therapy Design 2017 ·Cell stem cell ·Yonatan Y. Lipsitz, Patrick Bedford, (unknown), Nicholas Timmins, Peter W. Zandstra	30
3	Quality cell therapy manufacturing by design 2016 ·Nature Biotechnology ·Yonatan Y. Lipsitz, Nicholas Timmins, Peter W. Zandstra	214
4	At last, NICE to take over the Cancer Drugs Fund 2016 ·BMJ ·Nicholas Timmins	2
5	Transforming the Promise of Pluripotent Stem Cell-Derived Cardiomyocytes to a Therapy: Challenges and Solutions for Clinical Trials 2014 ·Canadian Journal of Cardiology ·Andrew B.J. Prowse, Nicholas Timmins, Terrence M. Yau, Ren‐Ke Li, Richard D. Weisel, Gordon Keller, Peter W. Zandstra	20
6	Enhanced Gametocyte Formation in Erythrocyte Progenitor Cells: A Site-Specific Adaptation by Plasmodium falciparum 2013 ·The Journal of Infectious Diseases ·Christopher L. Peatey, Jolanta A. Watson, Katharine R. Trenholme, Christopher L. Brown, (unknown), (unknown), Nicholas Timmins, Gregory S. Watson, Donald L. Gardiner	17
7	Bioreactor for Blood Product Production 2012 ·SHILAP Revista de lepidopterología ·Michael R. Doran, (unknown), (unknown), Nicholas Timmins, Kerry Atkinson, Lars K. Nielsen	7
8	Metabolite profiling of CHO cells with different growth characteristics 2012 ·Biotechnology and Bioengineering ·Stefanie Dietmair, Mark P. Hodson, Lake‐Ee Quek, Nicholas Timmins, Panagiotis K. Chrysanthopoulos, Shana Jacob, Peter P. Gray, Lars K. Nielsen	94
9	A Multi-Omics Analysis of Recombinant Protein Production in Hek293 Cells 2012 ·PLoS ONE ·Stefanie Dietmair, Mark P. Hodson, Lake‐Ee Quek, Nicholas Timmins, Peter P. Gray, Lars K. Nielsen	101
10	Ultra-High-Yield Manufacture of Red Blood Cells from Hematopoietic Stem Cells 2011 ·Tissue Engineering Part C Methods ·Nicholas Timmins, (unknown), (unknown), (unknown), Lars K. Nielsen	70
11	Mammalian cells as biopharmaceutical production hosts in the age of omics 2011 ·Biotechnology Journal ·Stefanie Dietmair, Lars K. Nielsen, Nicholas Timmins	36
12	Short-term exposure of umbilical cord blood CD34+ cells to granulocyte–macrophage colony-stimulating factor early in culture improves ex vivo expansion of neutrophils 2010 ·Cytotherapy ·(unknown), Nicholas Timmins, Lars K. Nielsen	13
13	Clinical scale ex vivo manufacture of neutrophils from hematopoietic progenitor cells 2009 ·Biotechnology and Bioengineering ·Nicholas Timmins, (unknown), (unknown), Stefanie Dietmair, (unknown), Genghis H. Lopez, Yoke Lin Fung, R. M. Minchinton, Lars K. Nielsen	39
14	NHS goes to the PROMS 2008 ·BMJ ·Nicholas Timmins	57
15	Farewell to dodging and weaving 2007 ·BMJ ·Nicholas Timmins	2
16	Generation of Multicellular Tumor Spheroids by the Hanging-Drop Method 2007 ·Methods in molecular medicine ·Nicholas Timmins, Lars K. Nielsen	179
17	Use of private health care in the NHS 2005 ·BMJ ·Nicholas Timmins	12
18	Challenges of private provision in the NHS 2005 ·BMJ ·Nicholas Timmins	17
19	Hanging-drop multicellular spheroids as a model of tumour angiogenesis 2004 ·Angiogenesis ·Nicholas Timmins, Stefanie Dietmair, Lars K. Nielsen	140
20	Identification of three gene candidates for multicellular resistance in colon carcinoma 2004 ·Cytotechnology ·Nicholas Timmins, Tina L. Maguire, Sean M. Grimmond, Lars K. Nielsen	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact